Zhou Jingyang, Che Jinhui, Xu Lu, Yang Weizhong, Zhou Wuyuan, Zhou Cuncai
Queen Mary School, Nanchang University, Nanchang 330006, PR China.
Department of Hepatopancreatobillary Surgery, Xuzhou City Cancer Hospital, Xuzhou 221005, PR China.
Dig Liver Dis. 2022 Apr;54(4):543-553. doi: 10.1016/j.dld.2021.07.005. Epub 2021 Sep 5.
We explored whether tumor-derived extracellular vesicles (EVs) could deliver long noncoding RNA (lncRNA) PART1 into macrophage to orchestrate macrophage polarization in the progression of hepatocellular carcinoma (HCC).
The expression patterns of PART1, microRNA (miR)-372-3p and TLR4 were detected by RT-qPCR in the HCC tissues and HCC cells. PART1 was silenced or overexpressed in HCC cells to assess its effects on the HCC cell process. EVs were isolated from PART1-overexpressed HCC cells, and co-cultured with macrophages, and gain- and loss-of-function assays were implemented in macrophages to evaluate their role in macrophage polarization. Relationship among PART1, miR-372-3p, and TLR4 was evaluated. Effect of EV-PART1 on tumorigenicity in vivo was detected by subcutaneous tumorigenicity test in nude mice.
PART1 and TLR4 were upregulated while miR-372-3p was downregulated in HCC tissues and cells. PART1 increased HCC cell proliferation, migration, invasion, and EMT. Mechanistically, PART1 bound to miR-372-3p to downregulate its expression, whereas TLR4 was negatively targeted by miR-372-3p in the macrophages. EVs containing PART1, TLR4 overexpression, or miR-372-3p inhibition induced M2 polarization of macrophages. Also, EVs containing PART1 promoted M2 polarization of macrophages and the occurrence of HCC by affecting miR-372-3p/TLR4 axis.
HCC cell-derived EVs might up-regulate TLR4 by inhibiting miR-372-3p via PART1 delivery to promote macrophage M2 polarization in HCC.
我们探究了肿瘤来源的细胞外囊泡(EVs)是否能将长链非编码RNA(lncRNA)PART1递送至巨噬细胞,从而在肝细胞癌(HCC)进展过程中调控巨噬细胞极化。
采用RT-qPCR检测HCC组织及HCC细胞中PART1、微小RNA(miR)-372-3p和Toll样受体4(TLR4)的表达模式。在HCC细胞中沉默或过表达PART1,以评估其对HCC细胞进程的影响。从过表达PART1的HCC细胞中分离出EVs,并与巨噬细胞共培养,在巨噬细胞中进行功能获得和功能缺失实验,以评估它们在巨噬细胞极化中的作用。评估PART1、miR-372-3p和TLR4之间的关系。通过裸鼠皮下致瘤性试验检测EV-PART1对体内致瘤性的影响。
在HCC组织和细胞中,PART1和TLR4上调,而miR-372-3p下调。PART1促进了HCC细胞的增殖、迁移、侵袭和上皮-间质转化。机制上,PART1与miR-372-3p结合以下调其表达,而在巨噬细胞中TLR4是miR-372-3p的负向靶标。含有PART1、TLR4过表达或miR-372-3p抑制的EVs诱导巨噬细胞发生M2极化。此外,含有PART1的EVs通过影响miR-372-3p/TLR4轴促进巨噬细胞M2极化和HCC的发生。
HCC细胞来源的EVs可能通过PART1传递抑制miR-372-3p,从而上调TLR4,促进HCC中巨噬细胞的M2极化。